mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.009 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.009 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |